Clinical Trial Update: Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer [NA]

View source ↗

Summary

A clinical trial evaluating celecoxib for pain, weight loss, and weakness in advanced cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cachexia
• Lymphoma
• Melanoma
• Ovarian Cancer
• Sarcoma
• Unspecified Adult Solid Tumor

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Cachexia, Lymphoma | NA | Status: WITHDRAWN